Archives

by in
Entry Author Date Location
In Need Of Revenues, Aastrom Buys Sanofi’s Cell Therapy Products 04/25/14 Detroit
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More 03/28/14 Boston
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
San Diego Life Sciences Roundup: Isis, Receptos, Suneva, and More 01/17/14 San Diego
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Alnylam Wheels, Deals, and Gets $700M Investment From Genzyme 01/13/14 Boston
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
Modern Day Scrooges Are Ruining Our Health Care System 12/03/13 Seattle
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
Hologic, Fending off Icahn, Adopts Poison Pill to Deflect Takeover 11/21/13 Boston
Immunogen Halts Study as Cancer Drug Flops, Shares Fall 11/05/13 Boston
RapidMiner Reels In $5M, Makes Big Push in Boston for Big Data 11/04/13 Boston
Merrimack’s Cancer Drug Misses Mark in Mid-Stage Trial, Shares Tumble 10/30/13 Boston
Pharma Showing Interest in Open Systems for Drug Discovery 10/23/13 National
East Coast Biotech Roundup: Schenkein, PureTech/JDRF, Sage, & More 10/18/13 Boston
Regeneron, Sanofi Pass First Key Test With Cholesterol-Lowering Drug 10/16/13 New York
Harvard’s Verdine Blazing Trail for Scientific Entrepreneurs 10/07/13 National
The Human Genome Project Wasn’t Overhyped. The Payoff Just Took Time 10/03/13 National
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww? 09/30/13 National
Foundation Medicine Scores $106M in Upsized IPO 09/24/13 Boston
East Coast Life Sciences Roundup: NY Genome Center, Acceleron, Bind, & More 09/20/13 Boston
Meda Snaps Up Sequoia-Backed Acton Pharmaceuticals for $135M+ 08/30/13 Boston
La Jolla Institute Extends 25-Year Partnership with Japanese Pharma 07/31/13 San Diego
NEA, Genzyme Join $18M Round For Rare Disease Startup Edimer 07/30/13 Boston
Aegerion Shares Soar on New Numbers For Rare Disease Drug 07/30/13 Boston
Foundation Medicine Lays Groundwork For $86M IPO 07/29/13 Boston
Biogen’s Oral MS Drug Tops Estimates, Brings in $192M in First Quarter 07/25/13 Boston
East Coast Life Sciences Roundup: Verdine, Vedanta, Alnylam, & More 07/05/13 Boston
Harvard Professor Steps Down to Pilot Warp Drive Bio 07/02/13 Boston
Page 2 of 5 « previous page · next page »